Study highlights the need to train health professionals on gluten-free diet

The partnership builds on Tiba’s existing efforts to tackle influenza pandemic threats. Credit: fizkes/Shutterstock. Tiba Biotech, a US preclinical biopharmaceutical company based in Cambridge, Massachusetts,

The FDA approved two cell-based gene therapies, exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia), for sickle cell disease (SCD), the agency announced. Marking the first